CYTOKINETICS INC — Director's Dealing 2023

May 18, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2023-05-10

Reporting Person: Kaye Edward M. MD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-05-10	Common Stock	A	5000	—	Acquired	18347	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-05-10	Non-Qualified Stock Option (Right to Buy)	$37.89	A	10000	Acquired	2033-05-10	Common Stock (10000)	Direct

Footnotes

F1: Comprised of restricted stock units that will vest in full and in one installment on 05/10/2024.

F2: Options shall vest and become exercisable in 12 equal monthly installments, the first such installment vesting on 06/10/2023 and the last such installment vesting on 05/10/2024.